Dr. Ekolle has a strong experience is several neurodegenerative disease models with over 40 peer review publications and extensive expertise in small animal electrophysiology, brain surgeries, immunohistochemistry, advanced microscopy techniques, and image analysis. In 2023, he joined Experimentica Ltd as Senior Scientist and in 2026 was appointed to role of Associate Director, Histology.
Learn more
D. Navickė holds a Master’s degree in Biochemistry from Vilnius University, Lithuania. She joined the Experimentica team in 2021 as a Senior Scientist, responsible for R&D project development and the expansion of molecular biology laboratories and services. In 2022, she assumed leadership of the histology laboratory and personnel as Head of Histology and Molecular Biology. In May 2025, she was appointed Associate Director of Molecular Biology and Histology at Experimentica’s Vilnius site in Lithuania.
Learn more
Dr. Lelytė holds a Ph.D. degree in Biomedical Sciences from the University of Birmingham, UK. She joined the Experimentica team in 2018 as a scientist, gaining experience in preclinical in vivo studies modeling a range of ocular diseases. In May 2025, she was appointed as an Associate Director of In Vivo Pharmacology at Experimentica’s Vilnius site in Lithuania.
Learn more
Dr. Artem Shatillo has a multidisciplinary background, holding a Medical Doctor degree in Psychiatry (2005), software development training (2006), and doctoral training in Imaging and Neurobiology from the University of Eastern Finland (2009-2015).
Learn more
Dr. Kalesnykas earned his Ph.D. in Neuroscience in 2005 from the University of Kuopio and completed several postdoctoral fellowships studying the pathophysiology of glaucoma and ocular gene therapy. He currently serves as an Adjunct Professor of Experimental Ophthalmology at University of Tampere, Finland.
Learn more
Dr. Vähätupa holds a Ph.D. degree in Biomedicine from Tampere University, Finland. She joined Experimentica Ltd. as a project researcher in angiogenesis-related studies in 2015. In 2019, Dr. Vähätupa took a role of in vivo team project coordinator and senior scientist. In September 2020, she was appointed as Director of In Vivo Pharmacology at Kuopio site, Finland.
Learn more
Dr. Ragauskas holds a Ph.D. degree in Biology from Vytautas Magnus University, Lithuania. He joined the Experimentica team as a project researcher in 2013, where he gained experience in conducting in vivo preclinical studies for a large number of disease indications. In 2018, Dr. Ragauskas was appointed as Director of In Vivo Pharmacology at Experimentica UAB, Lithuania.
Learn more
Dr. Mering has over 30 years’ experience in the area of laboratory animal science, especially in animal welfare and quality control.
Learn more
Dr. Jenni J. Hakkarainen is a recognized expert in predictive in vitro models that accelerate drug discovery and de-risk development programs. Her expertise focuses on drug permeability and transport of compounds across biological barriers, including the cornea, blood-retina barrier, blood-brain barrier, and intestine.
Learn more
All our facilities are AAALAC accredited, reflecting our commitment to the highest standards of animal care in research.
Copyright: Experimentica Ltd. 2026
